These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 522828)

  • 41. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
    Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9.
    Iwamura T; Katsuki T; Ide K
    Jpn J Cancer Res; 1987 Jan; 78(1):54-62. PubMed ID: 3102439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
    Nishida K; Yoshikawa T; Kondo M; Thiele HG
    Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum antibodies in human pancreatic disease.
    Lendrum R; Walker G
    Gut; 1975 May; 16(5):365-71. PubMed ID: 1095452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer.
    Fabris C; Basso D; Meggiato T; Del Favero G; Piccoli A; Fogar P; Panozzo MP; Faggian D; Naccarato R
    Int J Pancreatol; 1990 Jan; 6(1):i-ii. PubMed ID: 2230355
    [No Abstract]   [Full Text] [Related]  

  • 46. [Introduction of a new laboratory marker for cancer of the pancreas (CA 19.9). Current experience].
    Nunes AP; Jukemura J; Machado MC; Scheinberg MA
    Rev Paul Med; 1986; 104(2):99-101. PubMed ID: 3468583
    [No Abstract]   [Full Text] [Related]  

  • 47. Limits of CEA and ferritin in the diagnosis of pancreatic cancer.
    Plebani M; Fabris C; Basso D; Del Favero G; Angonese C; Leandro G; Di Mario F; Burlina A; Naccarato R
    Int J Pancreatol; 1988; 3 Suppl 1():S113-7. PubMed ID: 3209864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The diagnosis of exocrine pancreatic disease: the present position reviewed.
    Waller SL
    Aust N Z J Med; 1980 Jun; 10(3):351-62. PubMed ID: 6157384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of pancreatic cystadenoma with high level of CEA in the cyst fluid].
    Nagai K; Hayakawa T; Noda A; Kondo T; Mizuno R; Hamano H; Murase T; Shibata T; Nimura Y; Otsuka K
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):922-5. PubMed ID: 6748307
    [No Abstract]   [Full Text] [Related]  

  • 50. [Study on the diagnosis of pancreatic cancer by serum RNase (author's transl)].
    Matsuura A; Takahashi Y; Kasugai T
    Nihon Shokakibyo Gakkai Zasshi; 1979 Aug; 76(8):1702-14. PubMed ID: 43907
    [No Abstract]   [Full Text] [Related]  

  • 51. Letter: Carcinoembryonic antigen in dermatoses.
    Ahmed AR; Chu TM
    Lancet; 1976 Aug; 2(7980):309-10. PubMed ID: 59878
    [No Abstract]   [Full Text] [Related]  

  • 52. Has the carcinoembryonic antigen been a valuable discovery?
    Neville AM
    Tumour Biol; 1988; 9(2-3):61-2. PubMed ID: 3399814
    [No Abstract]   [Full Text] [Related]  

  • 53. Immune mechanisms in chronic pancreatic disease. II. Serum precipitins to pancreatic homogenates in patients with pancreatic disease: preliminary clinical observations.
    Herskovic T; Alarcón-Segovia D; Bartholomew LG; Cain JC; Wakim KG
    Am J Dig Dis; 1966 Jan; 11(1):40-4. PubMed ID: 5900277
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor markers carbohydrate antigens CA 19-9 and CA-50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract.
    Harmenberg U; Wahren B; Wiechel KL
    Cancer Res; 1988 Apr; 48(7):1985-8. PubMed ID: 3349472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
    Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
    Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Letter: Plasma CEA concentrations in pancreatic disease.
    Lindstedt G; Lundberg PA; Rolny P
    Br Med J; 1975 Oct; 4(5987):43. PubMed ID: 1174925
    [No Abstract]   [Full Text] [Related]  

  • 57. Carcinoembryonic antigen. Quantitative variations in circulating levels in benign and malignant digestive tract diseases.
    Zamcheck N
    Adv Intern Med; 1974; 19():413-33. PubMed ID: 4592719
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunologic markers of pancreatic cancer in humans].
    Kulagin PP; Chalov VV
    Vopr Onkol; 1983; 29(8):62-7. PubMed ID: 6193639
    [No Abstract]   [Full Text] [Related]  

  • 59. [Concentration of serum carcinoembryonic antigen in diseases of the pancreas].
    Libman E; Glisić L; Lemberger J; Novaković R; Simić P
    Med Pregl; 1979; 32(7-8):309-12. PubMed ID: 522828
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.